Article info
PDFClinical science
Two-year outcomes of the MINIject drainage system for uncontrolled glaucoma from the STAR-I first-in-human trial
- Correspondence to Georges M Durr, Department of Ophthalmology, Centre Hospitalier Universitaire De Montréal (CHUM), 1051 Rue Sanguinet, Montreal, Quebec H2X 3E4, Canada; georgesdurr{at}gmail.com
Citation
Two-year outcomes of the MINIject drainage system for uncontrolled glaucoma from the STAR-I first-in-human trial
Publication history
- Received May 12, 2020
- Revised September 7, 2020
- Accepted September 16, 2020
- First published October 3, 2020.
Online issue publication
May 11, 2023
Article Versions
- Previous version (11 May 2023).
- Previous version (11 May 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.